METABOLIC DISORDERS
6-month administration of teriparatide improves spinal BMD in women with anorexia nervosa
This report has been verified
by one or more authors of the
original publication.
J Clin Endocrinol Metab. 2014 Apr;99(4):1322-9. doi: 10.1210/jc.2013-4105. Epub 2014 Jan 23
21 women with anorexia nervosa (according to DSM IV weight and psychiatric criteria), and a T-score of -2.5 or less, were randomized to self-administer a subcutaneous injection into the abdomen of either 20 ug teriparatide or placebo. The purpose of this study was to examine the effects of teriparatide (TPT) on bone mineral density and markers of bone turnover. Results indicated that TPT significantly increased bone mineral density at the posteroanterior spine and lateral spine, when compared to placebo. Although TPT had a similar effect on CTX, IGF-1 and sclerostin when compared to placebo, levels of P1NP, a marker of bone formation, improved to a significantly greater degree in the TPT group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
